BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8086628)

  • 1. Correlation between the number of mitotic figures and the percentage of Ki67-positive cells in non-Hodgkin's lymphomas.
    Huang G; Feller AC; Lennert K
    Chin Med Sci J; 1994 Mar; 9(1):16-9. PubMed ID: 8086628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
    Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G
    J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
    Miettinen M
    Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proliferative fraction in lymph nodes: a comparison of proliferating cell nuclear antigen morphometry to flow cytometry.
    Krauss JS; Pantazis CG; Chandler FW
    Ann Clin Lab Sci; 1992; 22(3):189-96. PubMed ID: 1354428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotypic analysis of extranodal non-Hodgkin's lymphomas in the oral cavity.
    Takahashi H; Fujita S; Okabe H; Tsuda N; Tezuka F
    Pathol Res Pract; 1993 Apr; 189(3):300-11. PubMed ID: 8332573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of cellular proliferative activity in 35 T-cell non-Hodgkin's lymphomas. Use of proliferating cell nuclear antigen and Ki-67 (MIB-1) antibodies and nucleolar organizer regions.
    Caulet-Maugendre S; Patey M; Granier E; Joundi A; Gentile A; Caulet T
    Anal Quant Cytol Histol; 1996 Oct; 18(5):337-44. PubMed ID: 8908304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of three cell proliferation-associated antigens, DNA polymerase alpha, Ki-67 antigen and transferrin receptor in nodal and cutaneous T-cell lymphomas.
    Mitani S; Tango T; Sonobe Y; Baba N; Nagatani T; Nomoto S; Mori S
    Int J Hematol; 1991 Oct; 54(5):385-93. PubMed ID: 1756249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferation in non-Hodgkin's lymphomas as determined by immunohistochemical double staining for Ki-67.
    Tominaga K; Yamaguchi Y; Nozawa Y; Abe M; Wakasa H
    Hematol Oncol; 1992; 10(3-4):163-9. PubMed ID: 1398512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferation activity in canine lymphomas.
    Sokołowska J; Micun J; Malicka E; Lechowski R
    Pol J Vet Sci; 2012; 15(4):727-34. PubMed ID: 23390763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Paraneoplastic lymphadenopathy].
    Melikian AL; Nikitin EA; Kaplanskaia IB; Frank GA
    Ter Arkh; 2007; 79(8):44-52. PubMed ID: 17926471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas.
    Drillenburg P; van der Voort R; Koopman G; Dragosics B; van Krieken JH; Kluin P; Meenan J; Lazarovits AI; Radaszkiewicz T; Pals ST
    Am J Pathol; 1997 Mar; 150(3):919-27. PubMed ID: 9060830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunohistochemical in situ demonstration of cytokines in Hodgkin and non-Hodgkin lymphoma].
    Müller H; Takeshita M; Krause J; Schuster K; Kikuchi M; Stutte HJ
    Verh Dtsch Ges Pathol; 1992; 76():164-8. PubMed ID: 1283251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of cell proliferation index in assessing histological prognostic categories in Hodgkin's disease. An immunohistochemical study with Ki67 and MIB-1 monoclonal antibodies.
    Abele MC; Valente G; Kerim S; Navone R; Onesti P; Chiusa L; Resegotti L; Palestro G
    Haematologica; 1997; 82(3):281-5. PubMed ID: 9234572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
    Nguyen PL; Harris NL; Ritz J; Robertson MJ
    Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of flow cytometry in the diagnosis of non- Hodgkin's lymphoma, Hodgkin's lymphoma, granulomatous inflammation and reactive lymph node specimens.
    Gunduz E; Celebioglu M; Meltem Akay O; Uskudar Teke H; Sahin Mutlu F; Gulbas Z
    J BUON; 2013; 18(3):739-45. PubMed ID: 24065493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistological analysis of the immunoreactivity of normal lymphoid cells and lymphomas with the monoclonal antibody OPD4.
    O'Grady J; Blaikie AJ; Howie SE; Salter DM; Krajewski AS
    J Pathol; 1991 Jun; 164(2):119-25. PubMed ID: 2072211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative quantitative study of Ki-67 antibody staining in 78 B and T cell malignant lymphoma (ML) using two image analyser systems.
    Caulet S; Lesty C; Raphael M; Schoevaert D; Brousset P; Binet JL; Diebold J; Delsol G
    Pathol Res Pract; 1992 Jun; 188(4-5):490-6. PubMed ID: 1409077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma.
    Hall PA; Richards MA; Gregory WM; d'Ardenne AJ; Lister TA; Stansfeld AG
    J Pathol; 1988 Mar; 154(3):223-35. PubMed ID: 2450981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of a new CD5 antibody for the diagnosis of T-cell and B-cell lymphoproliferative disorders in paraffin sections.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1997 Sep; 10(9):859-63. PubMed ID: 9310947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
    Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
    Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.